Scrip
More wins but some setbacks for pharma in US AWP litigation
01 February 2010
Nancy Faigen
New developments have taken place in ongoing cases regarding alleged fraud by pharma companies in the manipulation of average wholesale prices (AWP) sent to reporting services, otherwise. Both states and municipalities have sued the drug makers in what is known as the AWP litigation.
In a positive...
Please Login to read the full article.
01 February 2010
Nancy Faigen
In a positive...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Merck & Co alters safety monitoring and pays lawyer fees to end US Vioxx suits
- Merck & Co vows to fight $8 million jury award in US Fosamax jaw damage litigation
- Setback for Pfizer in appeal over Nigerian Trovan claims
- US appeals court upholds "reverse payment" deal but urges rehearing of the issue
COMMENT
Other Informa Comment
FEATURES
- European generics industry throws its weight behind IMPACT
- Anti-obesity drugs: an inventor's perspective
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
